标普和纳斯达克内在价值 联系我们

Cutera, Inc. CUTR NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
43/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$39.25
+40405.7%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Cutera, Inc. (CUTR) .

本页证实的标准:

  • VALUE (100/100, 通过) — 分析师目标价暗示上行空间 (+40405.7%).
  • 分析师共识目标价 $39.25 (+40405.7% 上行空间) — 华尔街分析师认为存在显著上行潜力。

SharesGrow 综合评分: 43/100 其中 1/7 项标准通过。

SharesGrow 7-Criteria Score
43/100
SG Score
View full scorecard →
价值
100/100
Price-to-Earnings & upside
Proven by this page
~
未來
52/100
Analyst consensus
→ Forecast
过去
25/100
→ Income
~
健康
50/100
Debt-to-Equity & liquidity
→ Health
护城河
15/100
→ Income
~
成长
48/100
→ Income
收入
10/100
→ Income

估值概览 — CUTR

估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.01
EV/EBITDA0.0
每股数据
EPS (TTM)$-8.19
每股账面价值$0.00
每股营收$10.68
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%
分析师目标价$39.25 (+40405.7%)

EPS:实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year EPS(稀释) 营收 净利润 净利润率
2014 $-0.74 $78.14M $-10.61M -13.6%
2015 $-0.32 $94.76M $-4.44M -4.7%
2016 $0.19 $118.06M $2.58M 2.2%
2017 $2.04 $151.49M $29.99M 19.8%
2018 $-2.23 $162.72M $-30.77M -18.9%
2019 $-0.88 $181.71M $-12.35M -6.8%
2020 $-1.43 $147.68M $-23.88M -16.2%
2021 $0.11 $231.27M $2.06M 0.9%
2022 $-4.39 $252.4M $-82.34M -32.6%
2023 $-8.19 $212.37M $-162.83M -76.7%
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言